Bojer AS, Sorensen MH, Bjerre J, Gaede P, et al. Metabolic improvement with short-term glucagon like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients type 2 diabetes: a randomized double-blind placebo-controlled trial. Diabetes Obes Metab 2021 Jun 29. doi: 10.1111/dom.14480.
PMID: 34189832